A forecast of the year by Bill Kerr, M.D., MBA, CEO of Avalon Healthcare Solutions.
As 2025 approaches, the healthcare landscape is undergoing rapid transformation. Rising healthcare utilization, escalating costs and surging demand for specialized drugs like GLP-1 [glucagon-like peptide 1] therapies are intensifying the need for innovative solutions. One critical strategy lies in harnessing the power of lab data.
Kerr
By leveraging comprehensive lab insights, payers and employers can identify patients eligible for targeted treatments, stratify them by risk and ensure that costly medications are prescribed judiciously. This data-driven approach not only helps manage expenses but also improves patient outcomes.
Updated: UnitedHealth Group’s First Quarter Revenue Increases, But Company Revises Outlook
Published: April 17th 2025 | Updated: April 17th 2025The insurer’s healthcare expenses, especially physician and outpatient services, within the Medicare Advantage businesses were above what company leaders had expected.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen